the australian still happy, page-2

Very, very oversold this one.

I sold at 51c, thinking she might drift lower. But I've watched it go down & down.

I'm back in today at 17.5c, as I think it might have bottomed. Tax loss selling should be coming to an end soon.

What started the rot was sales uptake in the US has been slower than expected, but is expected to gain traction (& a bit or currency going the wrong way).

But this stock is 1/3 what it was, and:

~ has growing sales, up 151% for the year to March.
~ will soon be cash flow positive.
~ has enough money to fund to cash flow positive.
~ is going to have less costs soon, as trials are finishing.
~ good trials data will start to flow through.
~ more sales traction, as the product is used by more health authorities.
~ more indications for Brainz monitors to be used coming up.
~ more consumerables sales.
~ GE Healthcare is their partner, part of the world's biggest company.
~ takeover target, from the above.

All imho.